- Home
- DXLG vs EDAP Comparison
DXLG vs EDAP Comparison
Compare DXLG & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXLG
- EDAP
- Stock Information
- Founded
- DXLG 1976
- EDAP 1979
- Country
- DXLG United States
- EDAP France
- Employees
- DXLG N/A
- EDAP N/A
- Industry
- DXLG Clothing/Shoe/Accessory Stores
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DXLG Consumer Discretionary
- EDAP Health Care
- Exchange
- DXLG Nasdaq
- EDAP Nasdaq
- Market Cap
- DXLG 64.0M
- EDAP 53.8M
- IPO Year
- DXLG 1987
- EDAP 1997
- Fundamental
- Price
- DXLG $1.15
- EDAP $1.67
- Analyst Decision
- DXLG Strong Buy
- EDAP Buy
- Analyst Count
- DXLG 1
- EDAP 3
- Target Price
- DXLG $2.50
- EDAP $8.50
- AVG Volume (30 Days)
- DXLG 632.5K
- EDAP 30.8K
- Earning Date
- DXLG 05-29-2025
- EDAP 05-15-2025
- Dividend Yield
- DXLG N/A
- EDAP N/A
- EPS Growth
- DXLG N/A
- EDAP N/A
- EPS
- DXLG N/A
- EDAP N/A
- Revenue
- DXLG $457,059,000.00
- EDAP $67,840,467.00
- Revenue This Year
- DXLG N/A
- EDAP N/A
- Revenue Next Year
- DXLG $3.56
- EDAP N/A
- P/E Ratio
- DXLG N/A
- EDAP N/A
- Revenue Growth
- DXLG N/A
- EDAP 3.69
- 52 Week Low
- DXLG $0.90
- EDAP $1.26
- 52 Week High
- DXLG $3.93
- EDAP $5.46
- Technical
- Relative Strength Index (RSI)
- DXLG 49.13
- EDAP 39.78
- Support Level
- DXLG $0.98
- EDAP $1.62
- Resistance Level
- DXLG $1.09
- EDAP $1.80
- Average True Range (ATR)
- DXLG 0.07
- EDAP 0.10
- MACD
- DXLG -0.00
- EDAP 0.00
- Stochastic Oscillator
- DXLG 36.40
- EDAP 26.92
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.